The foregoing descriptions of each of the Notes, Note Purchase Agreement, First Amendment to Note Purchase Agreement, Registration Rights Agreement, First Amendment to Registration Rights Agreement, and Assignment Agreement (collectively, the “Agreements”) are qualified in their entirety by reference to each of the Agreements, which are filed as exhibits to the Issuer’s Form 8-K filed with the SEC on June 28, 2021 and are incorporated herein by reference.
The Reporting Persons acquired the securities covered by this Schedule 13D for investment purposes. Depending upon overall market conditions, changes in the Issuer’s operations, business strategy or prospects, other investment opportunities available to the Reporting Persons and the availability of shares of Common Stock at prices that would make the purchase or sale of shares of Common Stock desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of shares of Common Stock in the open market, private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable.
The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors including, without limitation, the Issuer’s financial position and investment strategy, the price levels of the shares of Common Stock, conditions in the securities markets and general economic and industry conditions, the Reporting Persons intend to continue to consider, explore and/or develop plans and may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, engaging in communications with the Issuer’s management and board of directors (the “Board”), engaging in discussions with shareholders of the Issuer and others about the Issuer and the Reporting Persons’ investment, making proposals to the Issuer concerning changes to the capital allocation strategy, capitalization, ownership structure, strategic transactions, including business combinations, a sale of the Issuer as a whole or in parts or acquisitions or investments by the Issuer, Board structure (including Board composition), operations of the Issuer, purchasing additional shares of Common Stock, selling some or all of their shares of Common Stock, engaging in short selling of or any hedging or similar transaction with respect to the shares of Common Stock, or take any other actions with respect to their investment in the Issuer permitted by law, including any or all of the actions set forth in paragraphs (a)-(j) of Item 4 of Schedule 13D. The Reporting Persons may at any time reconsider and change their plans or proposals relating to the foregoing.
Item 5. | Interest in Securities of the Issuer. |
(a)—(b) Each Reporting Person’s beneficial ownership of the Common Stock as of the date of this Schedule 13D is reflected on that Reporting Person’s cover page. The Reporting Persons may be deemed to be the beneficial owners of an aggregate of 25,711,113 shares of Common Stock.
THRC Holdings may be deemed to directly beneficially own 12,956,011 shares of Common Stock, representing 12.2% of the issued and outstanding shares of Common Stock, based on (i) 93,377,516 shares of Common Stock outstanding as of June 23, 2021, as represented by the Issuer in the Note Purchase Agreement, plus (ii) 12,755,102 shares of Common Stock issuable to THRC Holdings upon conversion of $12,500,000 in aggregate principal amount of the Notes. THRC Management, as General Partner of THRC Holdings, has exclusive voting and investment power over securities beneficially owned by THRC Holdings, and therefore, may be deemed to share beneficial ownership of such securities. Dan Wilks, as sole Manager of THRC Management, together with his spouse, Staci Wilks, who share the same household, may be deemed to exercise voting and investment power over securities beneficially owned by THRC Holdings, and therefore, Mr. Dan Wilks and Ms. Staci Wilks may each be deemed to share beneficial ownership of such securities.
Farris Wilks may be deemed to directly beneficially own 12,755,102 shares of Common Stock, representing 12.0% of the issued and outstanding shares of Common Stock, based on (i) 93,377,516 shares of Common Stock outstanding as of June 23, 2021, as represented by the Issuer in the Note Purchase Agreement, plus (ii) 12,755,102 shares of Common Stock issuable to Farris Wilks upon conversion of $12,500,000 in aggregate principal amount of the Notes.
(c) The transactions in the shares of Common Stock during the past sixty (60) days are set forth in Schedule I and are incorporated herein by reference.
(d) No person other than the Reporting Persons is known to have the right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, the shares of Common Stock.
9